(PRWEB) October 21, 2013
WHAT: Millennium Laboratories, a leader in the science of toxicology and pharmacogenetics, will host a breakfast session entitled: The Economic Impact of Opioid Abuse and Clinical Value to Medication Monitoring at Medicaid Health Plans of America 2013 (MHPA 2013), the country’s largest gathering of Medicaid health plan industry executives, in National Harbor, Md. on Tuesday, Oct. 22. For more information, visit Millennium Laboratories at booth #112.
WHO: Angela Huskey, PharmD, CPE, vice president of clinical practice, Millennium Laboratories and research scientist, Millennium Research Institute and Ira Kornbluth, MD, founder of SMART Pain Management will present.
WHY: Attendees of the session at MHPA 2013 will gain an understanding of the clinical value of urine drug testing (UDT) as an objective, evidence-based monitoring tool to aid prescribers in identifying potential misuse, abuse or diversion, as part of a multipronged approach. Huskey will present data from an analysis showing a potential net-benefit for urine drug testing in a population of Medicaid patients with pain. Millennium believes this preliminary investigation is the first time that economic data has been used to show the predictive value of UDT and requires additional investigation and validation in coordination with Millennium’s contracted Medicaid providers.
WHO SHOULD ATTEND: Registered MHPA 2013 attendees may attend. Attendance is limited and available on a first come first served basis. Click here to register http://www.mhpa.org/Events/MHPA_2013/. Members of the media may attend this conference free of charge by contacting Joe Reblando, JReblando(at)mhpa(dot)org.
WHEN: Tuesday, October 22, 7:30 to 8:30 a.m. Breakfast will be served.
WHERE: Gaylord National Resort & Convention Center, Baltimore Room 1-2, 201 Waterfront St., National Harbor, Md. 20745. For more information, please visit Millennium Laboratories at booth #112.
About Millennium Laboratories
Millennium Laboratories, a leader in the science of toxicology and pharmacogenetics, is transforming the way health care professionals monitor and manage their patients’ medication therapy. Through the use of advanced technology, supported by research and education, Millennium helps practitioners personalize care for patients. More information can be found at http://www.millenniumlabs.com.